Alpha 2.0
Login Register
» Articles » PMID: 29957028

Cellular Target Engagement: a New Paradigm in Drug Discovery

Overview
Journal Future Med Chem
Specialties Chemistry
Pharmacy
Date 2018 Jun 30
PMID 29957028
Citations 6
Authors
Ivan Babic
Santosh Kesari
Elmar Nurmemmedov
Affiliations
Soon will be listed here.
Citing Articles

Design and characterization of a time-domain optical tomography platform for mesoscopic lifetime imaging.

Gao S, Li M, Smith J, Intes X Biomed Opt Express. 2022; 13(9):4637-4651.

PMID: 36187247 PMC: 9484415. DOI: 10.1364/BOE.460216.

Why 90% of clinical drug development fails and how to improve it?.

Sun D, Gao W, Hu H, Zhou S Acta Pharm Sin B. 2022; 12(7):3049-3062.

PMID: 35865092 PMC: 9293739. DOI: 10.1016/j.apsb.2022.02.002.

Structure‒tissue exposure/selectivity relationship (STR) correlates with clinical efficacy/safety.

Gao W, Hu H, Dai L, He M, Yuan H, Zhang H Acta Pharm Sin B. 2022; 12(5):2462-2478.

PMID: 35646532 PMC: 9136610. DOI: 10.1016/j.apsb.2022.02.015.

Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis.

Kim M, Gernapudi R, Cedeno Y, Polster B, Martinez R, Shapiro P Oncotarget. 2020; 11(43):3863-3885.

PMID: 33196708 PMC: 7597410. DOI: 10.18632/oncotarget.27743.

Peptidomimetic Polo-Box-Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor.

Baxter M, Chapagai D, Craig S, Hurtado C, Varghese J, Nurmemmedov E ChemMedChem. 2020; 15(12):1058-1066.

PMID: 32232973 PMC: 7703809. DOI: 10.1002/cmdc.202000137.